Krishna Institute of Medical Sciences Ltd
NSE:KIMS

Watchlist Manager
Krishna Institute of Medical Sciences Ltd Logo
Krishna Institute of Medical Sciences Ltd
NSE:KIMS
Watchlist
Price: 645.45 INR 2.36% Market Closed
Market Cap: 258.3B INR
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one KIMS stock under the Base Case scenario is 642.14 INR. Compared to the current market price of 645.45 INR, Krishna Institute of Medical Sciences Ltd is Overvalued by 1%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

KIMS Relative Value
Base Case
642.14 INR
Overvaluation 1%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

9
P/S
P/S
Price to Sales
9
vs History
0
vs Industry
14
Median 3Y
5.9
Median 5Y
1.3
Industry
2.1
Forward
8.3
More Details
74.2
P/E
P/E
Price to Earnings
74.2
vs History
0
vs Industry
6
Median 3Y
43.9
Median 5Y
8.5
Industry
21.5
Forward
68.2
More Details
52
P/OCF
P/OCF
Price to OCF
52
vs History
0
vs Industry
5
Median 3Y
28.1
Median 5Y
6.2
Industry
13.2
More Details
68.2
P/FCFE
P/FCFE
Price to FCFE
68.2
vs History
27
vs Industry
6
Median 3Y
59.5
Median 5Y
55.8
Industry
18.8
More Details
12.9
P/B
P/B
Price to Book Value
12.9
vs History
0
vs Industry
4
Median 3Y
8
Median 5Y
1.9
Industry
2
More Details
9.5
EV/S
EV/S
Enterprise Value to Sales
9.5
vs History
0
vs Industry
12
Median 3Y
6.3
Median 5Y
1.5
Industry
2.2
Forward
8.7
More Details
12
EV/GP
EV/GP
Enterprise Value to Gross Profit
12
vs History
6
vs Industry
17
Median 3Y
8.4
Median 5Y
2.4
Industry
4.6
More Details
37.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
37.1
vs History
0
vs Industry
8
Median 3Y
24.3
Median 5Y
5.4
Industry
11.4
Forward
33.6
More Details
47.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
47.6
vs History
0
vs Industry
8
Median 3Y
30.6
Median 5Y
6.8
Industry
15.4
Forward
43.5
More Details
54.9
EV/OCF
EV/OCF
Enterprise Value to OCF
54.9
vs History
0
vs Industry
5
Median 3Y
30.2
Median 5Y
6.4
Industry
13
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-92.6
Median 5Y
-72.3
Industry
16.5
More Details
6.5
EV/IC
EV/IC
Enterprise Value to IC
6.5
vs History
0
vs Industry
12
Median 3Y
4.4
Median 5Y
1.7
Industry
1.8
More Details

Multiples Across Competitors

KIMS Competitors Multiples
Krishna Institute of Medical Sciences Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Krishna Institute of Medical Sciences Ltd
NSE:KIMS
258.3B INR 9 74.2 37.1 47.6
US
HCA Healthcare Inc
NYSE:HCA
83B USD 1.2 14.4 8.6 11.3
SA
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
98B SAR 8.7 42.3 37.1 43.8
ZA
Life Healthcare Group Holdings Ltd
JSE:LHC
20.9B Zac 0 0 0 0
ZA
Netcare Ltd
JSE:NTC
17.9B Zac 0 0 0 0
CN
Aier Eye Hospital Group Co Ltd
SZSE:300015
119.9B CNY 5.8 33 24.9 24.9
MY
IHH Healthcare Bhd
KLSE:IHH
60.1B MYR 2.5 22.6 11.9 17
IN
Max Healthcare Institute Ltd
NSE:MAXHEALTH
1T INR 16 103.9 62.4 75.5
IN
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
1T INR 4.8 76.9 36.3 47.9
US
Tenet Healthcare Corp
NYSE:THC
11.5B USD 0.6 3.6 5.3 6.7
US
Universal Health Services Inc
NYSE:UHS
11.3B USD 0.7 9.9 6.9 9.3

See Also

Summary
KIMS intrinsic value, competitors valuation, and company profile.
DCF Valuation
KIMS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
KIMS stock valuation using valuation multiples.
Wall Street Estimates
KIMS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
KIMS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 247,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.